The findings from the first Phase 3 study to assess the effect of a reversal agent for a specific NOAC in real-world emergency settings have been announced.
Latest Video
New Stories
-
The 'Week in Review' Podcast - 13 December
December 13, 2024 - - Podcast -
Report shows that weight is now the leading risk factor for Australia's disease burden
December 13, 2024 - - Latest News -
RACGP calls for free Meningococcal B vaccination program for Western Australia
December 12, 2024 - - Latest News -
Medicines Australia launches PBS explainer videos
December 12, 2024 - - Latest News -
This process has involved a lot of work for everyone and delivered very little
December 12, 2024 - - Latest News -
Immutep reports promising new data in head and neck cancer at ESMO immuno-oncology 2024
December 12, 2024 - - Australian Biotech -
What could the HTA Review change for patients who waited for this cancer therapy?
December 12, 2024 - - Latest News